Precision BioSciences Stock Price, News & Analysis (NASDAQ:DTIL)

$9.66
-0.39 (-3.88 %)
(As of 09/23/2019 06:00 AM ET)
Today's Range
$9.60
Now: $9.66
$10.10
50-Day Range
$7.97
MA: $9.34
$12.95
52-Week Range
$7.80
Now: $9.66
$19.00
Volume122,136 shs
Average Volume128,756 shs
Market Capitalization$489.09 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products in the United States. It operates through two segments, Therapeutic and Food. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene correction activities. This segment develops PBCAR0191, is an allogeneic CAR T cell therapy targeting the tumor target CD19 for acute lymphoblastic leukemia and non-hodgkin lymphoma; and CD20, BCMA, and CLL-1, CAR T cell therapies targeting the tumor antigens. The Food segment develops food and nutrition products; and pre-breeding materials, a gene edited crop intermediate that could be integrated into breeding program and use in producing new crop varieties. The company has development and commercial license agreement with Shire Plc for research and development of individual T cell modifications; collaboration agreement with Gilead Sciences, Inc. to co-develop a product candidate to cure chronic Hepatitis B infection. Precision BioSciences, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DTIL
CUSIPN/A
CIKN/A
Phone919-314-5512

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10.88 million

Profitability

Miscellaneous

Employees127
Market Cap$489.09 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive DTIL News and Ratings via Email

Sign-up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter.


Precision BioSciences (NASDAQ:DTIL) Frequently Asked Questions

What is Precision BioSciences' stock symbol?

Precision BioSciences trades on the NASDAQ under the ticker symbol "DTIL."

How were Precision BioSciences' earnings last quarter?

Precision BioSciences Inc (NASDAQ:DTIL) issued its earnings results on Wednesday, August, 14th. The company reported ($0.39) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.47) by $0.08. The company earned $5.39 million during the quarter, compared to analysts' expectations of $8.18 million. View Precision BioSciences' Earnings History.

When is Precision BioSciences' next earnings date?

Precision BioSciences is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for Precision BioSciences.

What price target have analysts set for DTIL?

6 brokers have issued 1-year price targets for Precision BioSciences' stock. Their forecasts range from $21.00 to $24.00. On average, they anticipate Precision BioSciences' stock price to reach $22.80 in the next twelve months. This suggests a possible upside of 136.0% from the stock's current price. View Analyst Price Targets for Precision BioSciences.

What is the consensus analysts' recommendation for Precision BioSciences?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Precision BioSciences in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Precision BioSciences.

Has Precision BioSciences been receiving favorable news coverage?

Headlines about DTIL stock have been trending somewhat negative recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Precision BioSciences earned a daily sentiment score of -1.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Precision BioSciences.

Are investors shorting Precision BioSciences?

Precision BioSciences saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 478,100 shares, an increase of 18.3% from the July 31st total of 404,100 shares. Based on an average trading volume of 171,200 shares, the days-to-cover ratio is presently 2.8 days. Approximately 1.5% of the shares of the stock are sold short. View Precision BioSciences' Current Options Chain.

Who are some of Precision BioSciences' key competitors?

What other stocks do shareholders of Precision BioSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Precision BioSciences investors own include Alibaba Group (BABA), JD.Com (JD), Baidu (BIDU), CVS Health (CVS), Johnson & Johnson (JNJ), TENCENT HOLDING/ADR (TCEHY), Intel (INTC), Lumentum (LITE), Momo (MOMO) and Micron Technology (MU).

Who are Precision BioSciences' key executives?

Precision BioSciences' management team includes the folowing people:
  • Mr. Matthew R. Kane, Co-Founder, CEO, Pres & Director (Age 42)
  • Dr. Derek Jantz Ph.D., Co-founder, Chief Scientific Officer & Director (Age 43)
  • Dr. Jefferson J. Smith Ph.D., Co-Founder & CTO
  • Mr. Abid Ansari, Chief Financial Officer (Age 41)
  • Ms. Molly Lukes PHR, SHRM-CP, Director of HR

When did Precision BioSciences IPO?

(DTIL) raised $126 million in an initial public offering (IPO) on Thursday, March 28th 2019. The company issued 7,900,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan, Goldman Sachs, Jefferies and Barclays acted as the underwriters for the IPO.

When does Precision BioSciences' lock-up period expire?

Precision BioSciences' lock-up period expires on Tuesday, September 24th. Precision BioSciences had issued 7,900,000 shares in its IPO on March 28th. The total size of the offering was $126,400,000 based on an initial share price of $16.00. After the end of Precision BioSciences' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Who are Precision BioSciences' major shareholders?

Precision BioSciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Cowen Inc. (2.15%), Cowen Inc. (2.15%), Wells Fargo & Company MN (1.75%), BlackRock Inc. (1.26%), Cormorant Asset Management LP (0.93%) and Vanguard Group Inc. (0.85%). Company insiders that own Precision BioSciences stock include Global Strategic Fund Venbio and Tony Dung Ling Yao. View Institutional Ownership Trends for Precision BioSciences.

Which institutional investors are selling Precision BioSciences stock?

DTIL stock was sold by a variety of institutional investors in the last quarter, including Cormorant Asset Management LP, JPMorgan Chase & Co. and Marshall Wace North America L.P.. View Insider Buying and Selling for Precision BioSciences.

Which institutional investors are buying Precision BioSciences stock?

DTIL stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, Vanguard Group Inc., Victory Capital Management Inc., Cowen Inc., Cowen Inc., Charles Schwab Investment Management Inc. and Northern Trust Corp. Company insiders that have bought Precision BioSciences stock in the last two years include Global Strategic Fund Venbio and Tony Dung Ling Yao. View Insider Buying and Selling for Precision BioSciences.

How do I buy shares of Precision BioSciences?

Shares of DTIL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Precision BioSciences' stock price today?

One share of DTIL stock can currently be purchased for approximately $9.66.

How big of a company is Precision BioSciences?

Precision BioSciences has a market capitalization of $489.09 million and generates $10.88 million in revenue each year. Precision BioSciences employs 127 workers across the globe.View Additional Information About Precision BioSciences.

What is Precision BioSciences' official website?

The official website for Precision BioSciences is http://www.precisionbiosciences.com/.

How can I contact Precision BioSciences?

Precision BioSciences' mailing address is 302 EAST PETTIGREW STREET SUITE A-100, DURHAM NC, 27701. The company can be reached via phone at 919-314-5512 or via email at [email protected]


MarketBeat Community Rating for Precision BioSciences (NASDAQ DTIL)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  24 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about Precision BioSciences and other stocks. Vote "Outperform" if you believe DTIL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DTIL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel